Windward Bio hits Nasdaq with $175M IPO, plus another $50M from Sanofi

Windward Bio, a biotech developing drugs for respiratory diseases, made its public debut after putting together $175 million in its IPO. The company began trading Friday with an initial share price {$WWB} of $17 apiece ...